Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

Nicholas Kwiatkowski(Dana-Farber Cancer Institute), Tinghu Zhang(Dana-Farber Cancer Institute), Peter B. Rahl(Whitehead Institute for Biomedical Research), Brian J. Abraham(Whitehead Institute for Biomedical Research), Jessica Reddy(Whitehead Institute for Biomedical Research), Scott B. Ficarro(Dana-Farber Cancer Institute), Anahita Dastur(Harvard University), Arnaud Amzallag(Massachusetts General Hospital), Sridhar Ramaswamy(Harvard University), Bethany Tesar(Dana-Farber Cancer Institute), Catherine E. Jenkins(BC Cancer Agency), Nancy M. Hannett(Whitehead Institute for Biomedical Research), Douglas W. McMillin(Dana-Farber Cancer Institute), Takaomi Sanda(Harvard University), Taebo Sim(Korea Institute of Science and Technology), Nam Doo Kim(Daegu-Gyeongbuk Medical Innovation Foundation), Thomas Look(Dana-Farber Cancer Institute), Constantine S. Mitsiades(Dana-Farber Cancer Institute), Andrew P. Weng(BC Cancer Agency), Jennifer R. Brown(Harvard University), Cyril H. Benes(Harvard University), Jarrod A. Marto(Dana-Farber Cancer Institute), Richard A. Young(Massachusetts Institute of Technology), Nathanael S. Gray(Harvard University)
Nature
June 20, 2014
10.1038/nature13393
Cited by 899Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis